Solid Biosciences
SLDB
90 hedge funds and large institutions have $145M invested in Solid Biosciences in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 20 reducing their positions, and 18 closing their positions.
2,279% more call options, than puts
Call options by funds: $2.38M | Put options by funds: $100K
75% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 20
1.94% less ownership
Funds ownership: 92.86% → 90.92% (-1.9%)
2% less funds holding
Funds holding: 92 → 90 (-2)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
42% less capital invested
Capital invested by funds: $250M → $145M (-$105M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$5.49M |
| 2 |
JP Morgan Chase
New York
|
+$5.19M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
+$3.38M |
| 4 |
BlackRock
New York
|
+$1.42M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.06M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$5.47M |
| 2 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$3.19M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.09M |
| 4 |
Millennium Management
New York
|
-$2.18M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.65M |
SLDB Hedge Fund Activity: Q4 2024 in Review
90 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q4 2024, worth a combined $145M — down 42% from $250M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of SLDB and 16 opened new positions — a net loss of 2 holders — while 20 trimmed existing stakes and 35 added.
The largest buyer was Siren LLC, adding an estimated $5.49M. The largest seller was ADAR1 Capital Management, cutting an estimated $5.47M.
- 90 institutional investors held Solid Biosciences (SLDB) as of Q4 2024, down from 92 in Q3 2024.
- Funds reported $145M of Solid Biosciences stock for Q4 2024, down 42% quarter-over-quarter.
- 16 funds opened new Solid Biosciences positions in Q4 2024 and 18 closed out, a net change of -2 holders.
- The largest Solid Biosciences buyer in Q4 2024 was Siren LLC, an estimated $5.49M added.
- The largest Solid Biosciences seller in Q4 2024 was ADAR1 Capital Management, an estimated $5.47M sold.
Based on aggregated 13F filings for Q4 2024.